| |
| Issue |
Title |
| |
| Vol 103, No 2 (2025) |
Stages of Tuberculosis Infection, What's New? (Literature Review) |
Abstract
PDF (Rus)
|
|
L. V. Slogotskaya, O. V. Lovacheva, N. I. Klevno |
| |
| Vol 103, No 2 (2025) |
Ways to Enhance the Diagnosis of Pulmonary Sarcoidosis (Literature Review) |
Abstract
PDF (Rus)
|
|
Yu. S. Zinchenko, V. O. Polyakova, A. N. Muraviev, I. R. Tubeeva, S. V. Starevskaya, P. K. Yablonskiy |
| |
| Vol 103, No 1 (2025) |
Immunological and Genetic Features of the Human Body Associated with Respiratory Mycobacteriosis (Literature Review) |
Abstract
PDF (Rus)
|
|
A. D. Egorova, N. L. Karpina, V. V. Yeremeev |
| |
| Vol 102, No 6 (2024) |
A Modern View of Cough Pathophysiology |
Abstract
PDF (Rus)
|
|
A. V. Budnevskiy, S. N. Avdeev, E. S. Ovsyannikov, S. N. Feygelman |
| |
| Vol 102, No 6 (2024) |
Diabetes Mellitus and Thyroid Dysfunction in Tuberculosis Patients: Review of Epidemiological Studies |
Abstract
PDF (Rus)
|
|
N. V. Tursunova, N. V. Stavitskaya, S. V. Smerdin, M. A. Plekhanova, M. V. Vershinina, A. A. Gordeev |
| |
| Vol 102, No 5 (2024) |
Insights into Population Genetics and Phylogeography of Mycobacterium tuberculosis |
Abstract
PDF (Rus)
|
|
B. A. Tkhorenko, A. V. Meyer, T. V. Pyanzova, A. V. Lyamin, M. B. Lavryashina |
| |
| Vol 102, No 3 (2024) |
Lung Imaging for Suspected Tuberculosis in the Pregnant (Review) |
Abstract
PDF (Rus)
|
|
O. O. Vinokurova, A. S. Vinokurov, A. V. Petryaykin, V. N. Zimina, A. L. Yudin |
| |
| Vol 102, No 3 (2024) |
Sarcoidosis Phenotyping: Analysis of Current Approaches (Review) |
Abstract
PDF (Rus)
|
|
A. A. Vizel, S. N. Avdeev, I. Yu. Vizel, G. R. Shakirova |
| |
| Vol 102, No 2 (2024) |
Gut Microbiota and Pulmonary Tuberculosis (Literature Review) |
Abstract
PDF (Rus)
|
|
N. V. Yukhimenko, S. S. Sterlikova, M. F. Gubkina, S. I. Kayukova |
| |
| Vol 102, No 1 (2024) |
Strategy of the Host-Directed Therapy for Tuberculosis: the Importance of Interferon-Gamma in the Pathogenesis and Therapy of Tuberculosis Infection |
Abstract
PDF (Rus)
|
|
G. N. Mozhokina, A. G. Samoylova, A. V. Abramchenko, M. I. Romanova, I. A. Vasilyeva |
| |
| Vol 102, No 1 (2024) |
Treatment with Inhaled Antibiotics as One of the Measures to Combat Bacterial Resistance (Cystic Fibrosis is Used as an Example) |
Abstract
PDF (Rus)
|
|
A. V. Takhtamysheva |
| |
| Vol 101, No 6 (2023) |
Delamanid: Safety and Efficacy Analysis |
Abstract
PDF (Rus)
|
|
G. N. Mozhokina, A. G. Samoylova, I. A. Vasilyeva, A. V. Abramchenko |
| |
| Vol 101, No 5 (2023) |
Tolerability of Tuberculosis Chemotherapy in Children |
Abstract
PDF (Rus)
|
|
M. E. Lozovskaya, I. Yu. Motov, G. A. Novik |
| |
| Vol 101, No 5 (2023) |
Global tuberculosis burden in Russia and the world as a public health problem (historical and analytical review) |
Abstract
PDF (Rus)
|
|
Z. M. Zagdyn, N. V. Kobesov, L. I. Rusakova, T. P. Vasilyeva, O. Yu. Aleksandrova, A. S. Galoyan |
| |
| Vol 101, No 4 (2023) |
Genetic Aspects of Mycobacterium Tuberculosis Resistance to New Anti-Tuberculosis Drugs |
Abstract
PDF (Rus)
|
|
A. V. Kukurika, E. I. Veselova, A. B. Peregudova |
| |
| Vol 101, No 3 (2023) |
Current Methods of Prevention of Aminoglycoside Ototoxicity in Patients with Pulmonary Tuberculosis |
Abstract
PDF (Rus)
|
|
A. A. Solokha, N. V. Stavitskaya, Ya. Sh. Shvarts, S. V. Sklyuev, N. V. Tursunova |
| |
| Vol 101, No 1 (2023) |
Modern Concepts about the Role of Gut Microbiota in Development of Pulmonary Tuberculosis |
Abstract
PDF (Rus)
|
|
M. M. Yunusbaeva, L. Ya. Borodina, A. M. Zakirova, R. A. Sharipov, B. B. Yunusbayev |
| |
| Vol 100, No 11 (2022) |
Safety of chemotherapy of MDR/XDR-TB patients in high HIV prevalence settings |
Abstract
PDF (Rus)
|
|
A. V. Kukurika, E. I. Veselova, L. E. Parolina, O. V. Lovacheva |
| |
| Vol 100, No 8 (2022) |
Medications for Short-Course Chemotherapy of Drug Resistant Tuberculosis and Their Effect on the Host |
Abstract
PDF (Rus)
|
|
G. N. Mozhokina, A. G. Samoylova, I. A. Vasilyeva, A. E. Russkikh |
| |
| Vol 100, No 7 (2022) |
Modern View on Bronchiectasis in Children |
Abstract
PDF (Rus)
|
|
P. A. Frolov, M. A. Zhestkova, D. Yu. Ovsyannikov |
| |
| Vol 100, No 5 (2022) |
DprE1 inhibitors – a prospective target for development of antituberculosis drugs |
Abstract
PDF (Rus)
|
|
A. V. Kukurika |
| |
| Vol 100, No 3 (2022) |
Prospects for Expanding Drug Therapy for Multiple Drug Resistant and Extensively Drug Resistant Tuberculosis |
Abstract
PDF (Rus)
|
|
G. N. Mozhokina, A. G. Samoylov, I. А. Vasilyeva |
| |
| Vol 100, No 2 (2022) |
Video Observed Treatment is an Innovative Method of Tuberculosis Treatment Observation in Resource-Limited Health Care Settings |
Abstract
PDF (Rus)
|
|
N. A. Pavlyuchenkova, I. A. Vasilyeva, A. G. Samoylova, T. E. Tyulkova |
| |
| Vol 100, No 1 (2022) |
Clinical Significance of Melatonin in Bronchial Asthma |
Abstract
PDF (Rus)
|
|
А. V. Budnevskiy, S. N. Аvdeev, S. А. Kozhevnikova, L. N. Аntakova, E. S. Ovsyannikov, V. V. Shishkina |
| |
| Vol 99, No 12 (2021) |
Diagnosis of Tuberculosis Infection Activity by Methods of Transcriptional Analysis |
Abstract
PDF (Rus)
|
|
E. I. Rubakova, T. K. Kondratieva, A. S. Аpt |
| |
| Vol 99, No 9 (2021) |
Bronchial Asthma and COVID-19: Comorbidity Issues |
Abstract
PDF (Rus)
|
|
E. S. Ovsyannikov, S. N. Аvdeev, A. V. Budnevskiy, E. S. Drobysheva, I. A. Savushkina |
| |
| Vol 99, No 8 (2021) |
Lung Injury Induced by Antitumor Drugs: Prevalence, Certain Drugs and Their Mechanisms of Action. Part 2 |
Abstract
PDF (Rus)
|
|
N. V. Orlova, O. D. Ostroumova, E. V. Shikh, S. V. Smerdin, E. V. Rebrova, V. А. Dyo |
| |
| Vol 99, No 8 (2021) |
Sarcoidosis and COVID-19 |
Abstract
PDF (Rus)
|
|
V. L. Dobin, I. V. Panin |
| |
| Vol 99, No 7 (2021) |
Lung Injury Induced by Antitumor Drugs: Diagnosis, Features of the Clinical Course, Risk Factors, Differential Diagnosis, Treatment, and Prevention. Part 1 |
Abstract
PDF (Rus)
|
|
N. V. Orlovа, O. D. Ostroumovа, E. V. Shikh, S. V. Smerdin, E. V. Rebrovа, V. А. Dyo |
| |
| Vol 99, No 6 (2021) |
Pretomanid: Clinical Trials and Prospects to Be Used in Treatment Regimens for Multiple and Extensive Drug Resistant Tuberculosis |
Abstract
PDF (Rus)
|
|
A. V. Kukurika |
| |
| Vol 99, No 5 (2021) |
Clofazimine: History and Perspectives |
Abstract
PDF (Rus)
|
|
G. N. Mozhokina, A. G. Samoylova |
| |
| Vol 99, No 3 (2021) |
Specific parameters of iron metabolism in tuberculosis |
Abstract
PDF (Rus)
|
|
R. Yu. Аbdullаev, O. G. Komissаrovа, O. R. Terentievа |
| |
| Vol 99, No 2 (2021) |
COVID-19 and chronic obstructive pulmonary disease: what is known about the unknown |
Abstract
PDF (Rus)
|
|
E. S. Ovsyannikov, S. N. Avdeev, A. V. Budnevskiy, E. S. Drobysheva, A. Ya. Kravchenko |
| |
| Vol 99, No 1 (2021) |
Main achievements of low-dose computed tomography in lung cancer screening |
Abstract
PDF (Rus)
|
|
V. A. Gombolevskiy, V. Yu. Chernina, I. A. Blokhin, A. E. Nikolaev, A. A. Barchuk, S. P. Morozov |
| |
| Vol 98, No 7 (2020) |
Coronaviruses as causative agents of severe respiratory diseases |
Abstract
PDF (Rus)
|
|
А. E. Panova, I. B. Kulikova, D. А. Lagutkin, А. S. Vinokurov, M. V. Shulgina, I. А. Vasilyeva |
| |
| Vol 98, No 6 (2020) |
Contemporary approaches to the search for active drugs and chemotherapy regimens for tuberculosis treatment |
Abstract
PDF (Rus)
|
|
T. K. Lugovkinа, S. N. Skornyakov, E. I. Kildyushevа, E. A. Egorov |
| |
| Vol 98, No 5 (2020) |
Autoimmune component in the etiology of sarcoidosis |
Abstract
PDF (Rus)
|
|
A. A. Starshinova, A. M. Malkova, Yu. S. Zinchenko, N. Yu. Basantsova, D. A. Kudlay, P. K. Yablonskiy |
| |
| Vol 98, No 5 (2020) |
BCG vaccination as protection from COVID-19: epidemiological and molecular biological aspects |
Abstract
PDF (Rus)
|
|
Ya. Sh. Shvartz, N. V. Stavitskaya, D. A. Kudlay |
| |
| Vol 98, No 4 (2020) |
Novel coronavirus infection |
Abstract
PDF (Rus)
|
|
E. I. Veselova, A. E. Russkikh, G. D. Kaminskiy, O. V. Lovacheva, A. G. Samoylova, I. A. Vasilyeva |
| |
| Vol 98, No 1 (2020) |
Drug resistance of M. tuberculosis (historical aspects, current level of knowledge) |
Abstract
PDF (Rus)
|
|
I. A. Burmistrova, A. G. Samoylova, T. E. Tyulkova, E. V. Vaniev, G. S. Balasanyants, I. A. Vasilyeva |
| |
| Vol 97, No 10 (2019) |
Nephrotoxic characteristics of anti-tuberculosis drugs |
Abstract
PDF (Rus)
|
|
G. N. Mozhokina, A. G. Samoylova, Z. A. Zangieva |
| |
| Vol 97, No 8 (2019) |
Leflunomide as a potential second-line drug in the treatment of sarcoidosis |
Abstract
PDF (Rus)
|
|
A. A. Vizel, I. Yu. Vizel |
| |
| Vol 97, No 6 (2019) |
Specific features of the immune response to tuberculosis when drug susceptible and drug resistant strains of M. tuberculosis are detected |
Abstract
PDF (Rus)
|
|
L. A. Shovkun, D. A. Kudlay, N. Yu. Nikolenko, E. D. Kampos, G. G. Kharseeva |
| |
| Vol 97, No 4 (2019) |
Cardiac toxicity of fluoroquinolones and bedaquiline |
Abstract
PDF (Rus)
|
|
G. N. Mozhokinа, A. G. Sаmoylovа |
| |
| Vol 96, No 10 (2018) |
Eosinophils as a non-invasive marker to assess inflammatory activities in those suffering from chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
|
M. A. Kаrnаushkinа, R. S. Dаnilov |
| |
| Vol 96, No 10 (2018) |
Use of hepatoprotectors during tuberculosis chemotherapy: review of the Russian and international studies |
Abstract
PDF (Rus)
|
|
A. A. Stаrshinovа, E. N. Belyaevа, A. M. Pаnteleev, M. V. Pаvlovа |
| |
| Vol 96, No 9 (2018) |
About the standardization and quality of laboratory tests aimed at diagnostics and monitoring of tuberculosis chemotherapy |
Abstract
PDF (Rus)
|
|
D. V. Vаkhrushevа, I. A. Vаsilyevа |
| |
| Vol 96, No 8 (2018) |
UNDERSTANDING OF MYCOBACTERIUM TUBERCULOSIS EVOLUTION |
Abstract
PDF (Rus)
|
|
V. L. Dobin |
| |
| Vol 96, No 1 (2018) |
HISTORIC DEVELOPMENT OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE CLASSIFICATION |
Abstract
PDF (Rus)
|
|
A. V. Nikitin, L. V. Vasilyeva, E. P. Karpukhina, E. M. Tolstykh |
| |
| Vol 95, No 6 (2017) |
ROLE OF SYSTEMATIC INFLAMMATION IN THE DEVELOPMENT OF COMORBIDITY IN CASE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
Abstract
PDF (Rus)
|
|
V. A. Nikitin, L. V. Vаsilievа, E. M. Tolstykh, A. S. Nogovitsynа |
| |
| 1 - 50 of 50 Items |
|
